Similar articles for PMID: 24476201

Year	Number of Results
1948	1
1963	1
1969	1
1972	1
1983	2
1985	3
1986	1
1988	5
1989	2
1990	2
1991	2
1992	1
1993	4
1994	3
1995	4
1996	4
1997	4
1998	4
1999	4
2000	3
2001	4
2002	2
2003	3
2004	2
2005	4
2007	4
2008	6
2009	8
2010	7
2011	11
2012	5
2013	12
2014	14
2015	8
2016	16
2017	10
2018	9
2019	4
2020	6
2021	10
2022	7
2023	3
2024	0

1

Role of vaccine manufacturers in developing countries towards global healthcare by providing quality vaccines at affordable prices.

Jadhav S, Gautam M, Gairola S. Jadhav S, et al. Clin Microbiol Infect. 2014 May;20 Suppl 5:37-44. doi: 10.1111/1469-0691.12568. Epub 2014 Mar 7. Clin Microbiol Infect. 2014. PMID: 24476201 Free article. Review.

2

Developing Countries Vaccine Manufacturers Network: doing good by making high-quality vaccines affordable for all.

Pagliusi S, Leite LC, Datla M, Makhoana M, Gao Y, Suhardono M, Jadhav S, Harshavardhan GV, Homma A. Pagliusi S, et al. Vaccine. 2013 Apr 18;31 Suppl 2:B176-83. doi: 10.1016/j.vaccine.2012.11.060. Vaccine. 2013. PMID: 23598479 Review.

3

Developing Countries Vaccine Manufacturers Network (DCVMN): engaging to step up for vaccine discovery and access. Meeting report 2012.

Pagliusi S, Makhoana M, Datla M, Leite L, Hendriks J, Gholami A, Huang W, Gao Y, Jadhav S, Harshavardhan GV, Wu Y, Suhardono M, Homma A. Pagliusi S, et al. Vaccine. 2013 Jun 28;31(31):3111-5. doi: 10.1016/j.vaccine.2013.04.082. Epub 2013 May 15. Vaccine. 2013. PMID: 23684836

4

Emerging markets & emerging needs: developing countries vaccine manufacturers' perspective & its current status.

Jadhav SS, Gautam M, Gairola S. Jadhav SS, et al. Biologicals. 2009 Jun;37(3):165-8. doi: 10.1016/j.biologicals.2009.02.009. Epub 2009 Mar 26. Biologicals. 2009. PMID: 19328010

5

Economic analyses of rubella and rubella vaccines: a global review.

Hinman AR, Irons B, Lewis M, Kandola K. Hinman AR, et al. Bull World Health Organ. 2002;80(4):264-70. Bull World Health Organ. 2002. PMID: 12075361 Free PMC article. Review.

6

Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.

Peny JM, Gleizes O, Covilard JP. Peny JM, et al. Vaccine. 2005 Aug 31;23(37):4610-8. doi: 10.1016/j.vaccine.2005.04.044. Vaccine. 2005. PMID: 15979769

7

Expanded programme on immunization.

Keja K, Chan C, Hayden G, Henderson RH. Keja K, et al. World Health Stat Q. 1988;41(2):59-63. World Health Stat Q. 1988. PMID: 3176515

8

Vaccine requirements and priorities for developing countries.

Thongcharoen P. Thongcharoen P. J Med Assoc Thai. 1986 Sep;69(9):505-10. J Med Assoc Thai. 1986. PMID: 3794567

9

Vaccines, inspiring innovation in health.

Pagliusi S, Dennehy M, Kim H; DCVMN AGM Organizing Committee. Pagliusi S, et al. Vaccine. 2018 Nov 19;36(48):7430-7437. doi: 10.1016/j.vaccine.2018.05.035. Epub 2018 May 19. Vaccine. 2018. PMID: 29789241 Free PMC article.

10

The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries.

Jadhav S, Datla M, Kreeftenberg H, Hendriks J. Jadhav S, et al. Vaccine. 2008 Mar 20;26(13):1611-5. doi: 10.1016/j.vaccine.2008.01.034. Epub 2008 Feb 6. Vaccine. 2008. PMID: 18294742 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

200 results

Results by year